Barclays maintains MSTR at Overweight, raises target to $175
Barclays maintained its Overweight rating on MSTR and raised its strategy price target to $175.00 from $160.00, per Benzinga.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.